The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Open accessAbstract
Oxidation of LDL may contribute to atherogenesis, though the nature of the in vivo oxidant(s) remains obscure. Myeloperoxidase, the enzyme responsible for hypochlorous acid/hypochlorite (HOCl) production in vivo, is present in active form in human atherosclerotic lesions, and HOCl aggregates and transforms LDL into a high-uptake form for macrophages in vitro. Here we demonstrate HOCl-modified proteins in human lesions using an mAb raised against HOCl-modified LDL that recognizes HOCl-oxidized proteins but does not cross-react with Cu2+-, malondialdehyde-, or 4-hydroxynonenal-modified LDL. This antibody detected significantly more material in advanced atherosclerotic lesions than normal arteries, even though azide and methionine were included during sample work-up to inhibit myeloperoxidase and to scavenge HOCl. The epitope(s) recognized was predominantly cell associated and present in monocyte/macrophages, smooth muscle, and endothelial cells. The intima and cholesterol clefts stained more heavily than the center of the thickened vessels; adventitial staining was apparent in some cases. Immunostaining was also detected in a very early lesion from an accident victim, beside healthy areas that were unreactive. LDL oxidized by HOCl in vitro, but not native LDL, effectively competed with the epitopes in lesions for antibody binding. Density centrifugation of plaque homogenates and Western blot analysis showed that, in the apo B-containing lipoprotein fraction, the mAb recognized protein(s) of molecular mass greater than apo B, similar to those produced during oxidation of LDL with HOCl in vitro. Three major proteins were recognized by the anti-HOCl-modified protein antibody but not by an anti-apo B antibody in the apo B-free fraction. Together, these results demonstrate HOCl-oxidized proteins in human atherosclerotic lesions, implicating this oxidant in LDL modification in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Macrophage localization in the atherosclerotic plaque leads to detectable MPO activity and products of HOCl oxidation (213, 414).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Ylä‐Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S. S., Witztum, J. L., & Steinberg, D. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,877
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä‐Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D. H., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,514
Rg, G. (1981) · PubMed Central · Cited by 1,314
Stary, H. C., Chandler, A. B., Glagov, S. K., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Circulation · doi:10.1161/01.cir.89.5.2462 · Cited by 1,313
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssönen, K., Ylä‐Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,311
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Research works printed but not linked: 1
- Adams, D.O., and T.A. Hamilton. 1992. Macrophages as destructive cells in host defense. In Inflammation: Basic principles and clinical correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman. Raven Press, New York. 637- 662.
Cited by
Sorted by citations
Items 201–300 of 593
Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other
Av, S., Ageeva, K. V., Pulina, M. O., Cherkalina, O. S., Самыгина, В. Р., Vlasova, I. I., Panasenko, O. M., Zakharova, E. T., & Vasilyev, V. B. (2008) · Free Radical Research · doi:10.1080/10715760802566574 · Cited by 71
Marsche, G., Zimmermann, R., Horiuchi, S., Tandon, N. N., Sattler, W., & Malle, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308428200 · Cited by 71
Self-citationRegulation of Apoptosis by Vitamin C
Vissers, M. C. M., Lee, W.-G., & Hampton, M. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107664200 · Cited by 70
Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
Martín-Ventura, J. L., Rodrigues‐Díez, R., Martínez-López, D., Salaíces, M., Blanco‐Colio, L. M., & Briones, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112315 · Cited by 71
The development of myeloperoxidase inhibitors
Galijašević, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.11.031 · Cited by 70
Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice
Tiyerili, V., Camara, B., Becher, M. U., SCHRICKEL, J. W., Lütjohann, D., Mollenhauer, M., Baldus, S. E., Nickenig, G., & Andrié, R. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.11.128 · Cited by 70
Nguyen‐Khoa, T., Massy, Z. A., Witko‐Sarsat, V., Canteloup, S., Kebede, M., Lacour, B., Drüeke, T. B., & Descamps‐Latscha, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1438 · Cited by 70
Wu, S. M., Patel, D. D., & Pizzo, S. V. (1998) · PubMed · Cited by 70
Neužil, J., Weber, C., & Kontush, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00741-3 · Cited by 68
Upston, J. M., Neužil, J., Witting, P. K., Alleva, R., & Stocker, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30067 · Cited by 70
Self-citationBergt, C., Marsche, G., Panzenboeck, U., Heinecke, J. W., Malle, E., & Sattler, W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02253.x · Cited by 69
Self-citationContributions of Myeloperoxidase to Proinflammatory Events: More Than an Antimicrobial System
Nauseef, W. M. (2001) · International Journal of Hematology · doi:10.1007/bf02981994 · Cited by 69
Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite
Connelly, P. W., Draganov, D. I., & Maguire, G. F. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.010 · Cited by 68
A role for reduced coenzyme Q in atherosclerosis?
Thomas, S. R., Witting, P. K., & Stocker, R. (1999) · BioFactors · doi:10.1002/biof.5520090216 · Cited by 68
Self-citationMarsche, G., Levak‐Frank, S., Quehenberger, O., Heller, R., Sattler, W., & Malle, E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0532fje · Cited by 68
Self-citationAlfakry, H., Malle, E., Koyani, C. N., Pussinen, P. J., & Sorsa, T. A. (2015) · Innate Immunity · doi:10.1177/1753425915617521 · Cited by 71
Self-citationTheranostic applications of biomolecule‐responsive aggregation‐induced emission luminogens
Liao, Y., Peng, Z., Liu, X., Hu, Y., & Zhang, J. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230024 · Cited by 68
Lv, J., Wang, F., Wei, T., & Chen, X. (2017) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.7b00381 · Cited by 66
Chapman, A., Senthilmohan, R., Winterbourn, C. C., & Kettle, A. J. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1744 · Cited by 65
Liu, Y., Zhao, Z., Miao, J., & Zhao, B. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.03.045 · Cited by 64
Zhang, C., Nie, Q., Ismail, I., Xi, Z., & Yi, L. (2018) · Chemical Communications · doi:10.1039/c8cc01917g · Cited by 62
Boudjeltia, K. Z., Moguilevsky, N., Legssyer, I., Babar, S., Guillaume, M., Delrée, P., Vanhaeverbeek, M., Brohée, D., Ducobu, J., & Remacle, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.049 · Cited by 62
Hamilton, C. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00202-1 · Cited by 62
Reactive oxygen species and anti-proteinases
Siddiqui, T., Zia, M. K., Ali, S. S., Rehman, A. A., Ahsan, H., & Khan, F. H. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1115525 · Cited by 61
The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis
Ou, H.-X., Huang, Z., Mo, Z., & Xiao, J. (2016) · Cardiovascular Toxicology · doi:10.1007/s12012-016-9377-8 · Cited by 61
Oxidative Modifications of APOB-100 by Exposure of Low Density Lipoproteins to HOCl In Vitro
Yang, C., Gu, Z.-W., Yang, H.-X., Yang, M., Gotto, A. M., & Smith, C. V. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00624-7 · Cited by 60
Summers, F. A., Morgan, P. E., Davies, M. J., & Hawkins, C. L. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8001719 · Cited by 59
The High Atherosclerotic Risk Among Epileptics: the Atheroprotective Role of Multivitamins
Hamed, S. A., & Nabeshima, T. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05003x · Cited by 60
Wu, S. M., Patel, D. D., & Pizzo, S. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4356 · Cited by 79
Jiang, Y., Zheng, G., Duan, Q., Yang, L., Zhang, J., Zhang, H., He, J. H., Sun, H., & Ho, D. L. (2018) · Chemical Communications · doi:10.1039/c8cc03963a · Cited by 59
Relative reactivity of lysine and other peptide-bound amino acids to oxidation by hypochlorite
Nightingale, Z. D., Lancha, A. H., Handelman, S. K., Dolnikowski, G. G., Busse, S. C., Dratz, E. A., Blumberg, J. B., & Handelman, G. J. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00262-8 · Cited by 59
Kinetics of Hypobromous Acid-Mediated Oxidation of Lipid Components and Antioxidants
Skaff, O., Pattison, D. I., & Davies, M. J. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7003097 · Cited by 59
Urquiaga, I., Troncoso, D., Mackenna, M. J., Urzúa, C., Pérez, D., Dicenta, S., la Cerda, P. M. D., Amigo, L., Carreño, J. C., Echeverría, G., et al. (2018) · Nutrients · doi:10.3390/nu10101388 · Cited by 57
Neutrophil's weapons in atherosclerosis
Chistiakov, D. A., Bobryshev, Y. V., & Orekhov, A. N. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.11.011 · Cited by 63
Inhibition of hypochlorous acid-induced cellular toxicity by nitrite
Whiteman, M., Hooper, D. C., Scott, G. S., Koprowski, H., & Halliwell, B. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152462399 · Cited by 57
Kudchodkar, B. J., Wilson, J., Lacko, A. G., & Dory, L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1637 · Cited by 57
Davies, M. J., & Hawkins, C. L. (2000) · Free Radical Research · doi:10.1080/10715760000301241 · Cited by 57
Marsche, G., Semlitsch, M., Hammer, A., Frank, S., Weigle, B., Demling, N., Schmidt, K., Windischhofer, W., Waeg, G., Sattler, W., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7439com · Cited by 57
Self-citationLetters, J., Witting, P. K., Christison, J. K., Eriksson, A. W., Pettersson, K. S., & Stocker, R. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33514-8 · Cited by 57
Self-citationCook, N. L., Viola, H. M., Sharov, V. S., Hool, L. C., Schöneich, C., & Davies, M. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.001 · Cited by 56
Stamp, L. K., Turner, R., Khalilova, I. S., Zhang, M., Drake, J. M., Forbes, L. V., & Kettle, A. J. (2014) · Rheumatology · doi:10.1093/rheumatology/keu218 · Cited by 57
Munno, M., Mallia, A., Greco, A., Modafferi, G., Banfi, C., & Eligini, S. (2024) · Antioxidants · doi:10.3390/antiox13050583 · Cited by 63
Kulcharyk, P. A., & Heinecke, J. W. (2001) · Biochemistry · doi:10.1021/bi001962l · Cited by 55
Jenner, A. M., Ruiz, J. E., Dunster, C., Halliwell, B. B., Mann, G. E., & Siow, R. C. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013785.03265.5c · Cited by 55
Role of oxidized low-density lipoprotein in the atherosclerosis of uremia
Drüeke, T. B., Nguyen‐Khoa, T., Massy, Z. A., Witko‐Sarsat, V., Lacour, B., & Descamps‐Latscha, B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780114.x · Cited by 55
Dong, X., Zhang, G., Shi, J., Wang, Y., Wang, M., Peng, Q., & Zhang, D. (2017) · Chem. Commun. · doi:10.1039/c7cc07092f · Cited by 54
Gai, L., Mack, J. P., Liu, H., Xu, Z., Lü, H., & Li, Z. (2013) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2013.02.106 · Cited by 54
Ximenes, V. F., Maghzal, G. J., Turner, R., Kato, Y., Winterbourn, C. C., & Kettle, A. J. (2009) · Biochemical Journal · doi:10.1042/bj20090776 · Cited by 56
Hypochlorite scavenging activity of flavonoids
Firuzi, O., Mladěnka, P., Petrucci, R., Marrosu, G., & Saso, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023556 · Cited by 54
Myeloperoxidase-Catalyzed Oxidation of Tyrosine
Tien, M. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1226 · Cited by 54
Vaarala, O. (2000) · Lupus · doi:10.1191/096120300678828280 · Cited by 54
Nusshold, C., Kollroser, M., Köfeler, H. C., Rechberger, G. N., Reicher, H., Üllen, A., Bernhart, E. M., Waltl, S., Kratzer, I., Hermetter, A., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.037 · Cited by 53
Self-citationBozonet, S. M., Scott-Thomas, A., Nagy, P., & Vissers, M. C. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.028 · Cited by 53
Pandolfi, A., & Filippis, E. A. D. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0050-5 · Cited by 55
Wang, J., Cheng, D., Zhu, L., Wang, P., Liu, H., Chen, M., Yuan, L., & Zhang, X. (2019) · Chemical Communications · doi:10.1039/c9cc04736k · Cited by 54
Myeloperoxidase: a potential therapeutic target for coronary artery disease
Chaikijurajai, T., & Tang, W. H. W. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1762177 · Cited by 53
Poliakov, E., Brennan, M., MacPherson, J. C., Zhang, R., Sha, W., Narine, L., Salomon, R. G., & Hazen, S. L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0086com · Cited by 52
Human Low Density Lipoprotein as a Target of Hypochlorite Generated by Myeloperoxidase
Jerlich, A., Fabjan, J. S., Tschabuschnig, S., Smirnova, A. V., Horáková, Ľ., Hayn, M., Auer, H., Guttenberger, H., Leis, H., Tatzber, F., et al. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00439-5 · Cited by 52
Self-citationStanley, N., Stadler, N., Woods, A. A., Bannon, P. G., & Davies, M. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.031 · Cited by 51
Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
Abdo, A. I., Rayner, B. S., van Reyk, D. M., & Hawkins, C. L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.004 · Cited by 51
Upston, J. M., Neužil, J., & Stocker, R. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37468-x · Cited by 51
Self-citationKazzi, M. E., Rayner, B. S., Chami, B., Dennis, J. M., Thomas, S. R., & Witting, P. K. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7928 · Cited by 53
Ma, H., Song, B., Wang, Y., Liu, C., Wang, X., & Yuan, J. (2017) · Dyes and Pigments · doi:10.1016/j.dyepig.2017.01.062 · Cited by 50
He, M., Ye, M., Li, B., Wu, T., Lu, C., Liu, P., Li, H., Zhou, X., Wang, Y., Liang, T., et al. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131868 · Cited by 47
Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro
Marsche, G., Furtmüller, P. G., Obinger, C., Sattler, W., & Malle, E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn051 · Cited by 49
Self-citationMeasurement of Copper-Binding Sites on Low Density Lipoprotein
Roland, A., Patterson, R. A., & Leake, D. S. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.594 · Cited by 49
Liu, S., Yang, D. S., Liu, Y., Pan, H., Chen, H., Qu, X., & Li, H. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.126937 · Cited by 48
Moguilevsky, N., Boudjeltia, K. Z., Babar, S., Delrée, P., Legssyer, I., Carpentier, Y., Vanhaeverbeek, M., & Ducobu, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.220 · Cited by 48
Hypochlorous Acid Damages Histone Proteins Forming 3-Chlorotyrosine and 3,5-Dichlorotyrosine
Kang, J. I., & Neidigh, J. W. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7003486 · Cited by 47
Assessment of Myeloperoxidase Activity by the Conversion of Hydroethidine to 2-Chloroethidium
Maghzal, G. J., Cergol, K. M., Shengule, S. R., Suarna, C., Newington, D. L., Kettle, A. J., Payne, R. J., & Stocker, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.539486 · Cited by 47
Self-citationFluorescent Probes for HOCl Imaging
Hu, J. J., Ye, S., & Yang, D. (2017) · Israel Journal of Chemistry · doi:10.1002/ijch.201600113 · Cited by 47
Liu, C., Jiao, X., He, S., Zhao, L., & Zeng, X. (2017) · Talanta · doi:10.1016/j.talanta.2017.06.012 · Cited by 48
Kumar, K., Kaur, S., Kaur, S., Bhargava, G., Kumar, S., & Singh, P. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01902b · Cited by 47
Hazen, S. L., Gaut, J. P., Crowley, J. R., Hsu, F., & Heinecke, J. W. (2000) · Biochemical Journal · doi:10.1042/bj3520693 · Cited by 47
Fragmentation of extracellular matrix by hypochlorous acid
Woods, A. A., & Davies, M. J. (2003) · Biochemical Journal · doi:10.1042/bj20030715 · Cited by 45
Atherosclerosis and uremic retention solutes
Hörl, W. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00944.x · Cited by 46
Carr, A. C., & Frei, B. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009082200 · Cited by 46
Hypochlorite-Modified LDL: Chemotactic Potential and Chemokine Induction in Human Monocytes
Woenckhaus, C., Kaufmann, A. M., Bußfeld, D., Gemsa, D., Sprenger, H., & Gröne, H. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4453 · Cited by 46
Lloyd, M. M., Grima, M. A., Rayner, B. S., Hadfield, K. A., Davies, M. J., & Hawkins, C. L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.007 · Cited by 45
Cai, H., Chuang, C. Y., Hawkins, C. L., & Davies, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-019-57299-6 · Cited by 45
Yan, L., Lodge, J. K., Traber, M. G., Matsugo, S., & Packer, L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37223-0 · Cited by 44
Noguchi, N., Okimoto, Y., Tsuchiya, J., Cynshi, O., Kodama, T., & Niki, E. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0331 · Cited by 44
Bergt, C., Oettl, K., Keller, W., Andreae, F., Leis, H. J., Malle, E., & Sattler, W. (2000) · Biochemical Journal · doi:10.1042/bj3460345 · Cited by 44
Self-citationProatherogenic modification of LDL by surface-bound myeloperoxidase
Av, S., Kostevich, V. A., Runova, O. L., Gorudko, I. V., Vasilyev, V. B., Sn, C., & Panasenko, O. M. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.02.006 · Cited by 43
Iron and LDL‐oxidation in atherogenesis.
Yuan, X., & Brunk, U. T. (1998) · Apmis · doi:10.1111/j.1699-0463.1998.tb00229.x · Cited by 43
Degendorfer, G., Chuang, C. Y., Hammer, A., Malle, E., & Davies, M. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.018 · Cited by 42
Self-citationJia, P., Zhuang, Z., Liu, C., Wang, Z., Duan, Q., Li, Z., Zhu, H., Du, B., Zhu, B., Sheng, W., et al. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.11.031 · Cited by 42
Cai, H., Chuang, C. Y., Vanichkitrungruang, S., Hawkins, C. L., & Davies, M. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.044 · Cited by 41
Bergt, C., Reicher, H., Malle, E., & Sattler, W. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00677-8 · Cited by 41
Self-citationAutoantibodies against modified low-density lipoproteins in coronary artery disease
Tornvall, P. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00021-2 · Cited by 41
Halogenation Activity of Mammalian Heme Peroxidases
Arnhold, J., & Malle, E. (2022) · Antioxidants · doi:10.3390/antiox11050890 · Cited by 40
Self-citationChen, W.-C., Venkatesan, P., & Wu, S. (2015) · New Journal of Chemistry · doi:10.1039/c5nj01083g · Cited by 39
Stacey, M. M., Vissers, M. C. M., & Winterbourn, C. C. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4348 · Cited by 39
Chuang, C. Y., Degendorfer, G., Hammer, A., Whitelock, J. M., Malle, E., & Davies, M. J. (2014) · Biochemical Journal · doi:10.1042/bj20131471 · Cited by 39
Self-citationA new ratiometric fluorescent probe for sensing HOCl based on TBET in real time
Song, G., Ma, H., Luo, J., Cao, X., & Zhao, B. (2017) · Dyes and Pigments · doi:10.1016/j.dyepig.2017.09.022 · Cited by 38
Probucol Protects against Hypochlorite-induced Endothelial Dysfunction
Witting, P. K., Wu, B. J., Raftery, M. J., Southwell‐Keely, P. T., & Stocker, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414256200 · Cited by 39
Self-citationFormation of Active Oxygen Species and Lipid Peroxidation Induced by Hypochlorite
Noguchi, N., Nakada, A., Itoh, Y., Watanabe, A., & Niki, E. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2689 · Cited by 39
Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo
Gujral, J. S., Hinson, J., & Jaeschke, H. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s48 · Cited by 38
Boon, A., Hawkins, C. L., Coombes, J. S., Wagner, K., & Bulmer, A. C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.031 · Cited by 38
Carr, A. C., & Frei, B. B. (2002) · Biological Chemistry · doi:10.1515/bc.2002.065 · Cited by 38
Metadata
- Authors
- Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R.
- Affiliations
- The Heart Research Institute (AU)
- The University of Sydney (AU)
- University of Graz (AT)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1996-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1535-1544
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507214
- OpenAlex
- W2118480498
- Cited by
- 592
- References
- 39
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 14 · 2023: 14 · 2022: 19 · 2021: 12 · 2020: 18 · 2019: 20 · 2018: 26 · 2017: 16 · 2016: 12 · 2015: 17 · 2014: 15 · 2013: 13 · 2012: 16
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Austrian Science Fund
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- hypochlorite, myeloperoxidase, atherosclerosis, LDL oxidation, oxidized LDL, atherosclerotic plaque, macrophages, smooth muscle cells, endothelial cells, oxidizing agents, atherogenesis
- MeSH terms
- Arteriosclerosis, Humans, Hypochlorous Acid, Immunohistochemistry, Lipoproteins, LDL, Oxidation-Reduction, Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review